CLEVELAND – When Mike Mahoney took the helm of Boston Scientific Corp. in 2012, the company had little to no growth and was bogged down in litigation tied to its acquisition of Guidant Corp. The firm was also mainly focused on cardiovascular solutions. Fast forward to 2017 and the Marlborough, Mass.-based company has fully emerged from past turmoil. Mahoney spoke about Boston Scientific's turnaround in a fireside chat held on the second day of the Cleveland Clinic's 2017 Medical Innovation Summit.